Clinical Trials Logo

Prostate Cancer Recurrent clinical trials

View clinical trials related to Prostate Cancer Recurrent.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT04452136 Approved for marketing - Prostate Cancer Clinical Trials

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Start date: n/a
Phase:
Study type: Expanded Access

This study provides expanded access to radiotracer Gallium 68 (68Ga)-prostate-specific membrane antigen (PSMA)-HBED-CC (68Ga-PSMA-11) with Positron Emission Tomography (PET) imaging for participants with intermediate and high risk prostate cancer before prostatectomy or for suspected biochemical recurrence of their prostate cancer. Compared to conventional imaging, 68Ga PSMA-HBED-CC might improve the ability to localize the sites of recurrent or metastatic disease, which helps with surgical and other treatment planning.